Myung Jin Ban, Chang Hwan Ryu, Joo Hyun Woo, Young Chan Lee, Dong Kun Lee, Minsu Kwon, Yong Tae Hong, Gil Joon Lee, Hyung Kwon Byeon, Seung Ho Choi & Seung Won Lee. (2023) Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force. Clinical and Experimental Otorhinolaryngology 16:4, pages 291-307.
Crossref
Emrah Kağan Yaşar, Batuhan Polat & Murat Şahin Alagöz. (2023) An Alternative Method to Prevent Frey Syndrome After Resection of Huge Masses in Parotis: De-epithelialized Skin Flap Use. Journal of Craniofacial Surgery 34:5, pages e531-e533.
Crossref
Mitchell F. Brin & Rami Burstein. (2023) Botox (onabotulinumtoxinA) mechanism of action. Medicine 102:S1, pages e32372.
Crossref
Natalie Anne Watson, Zohaib Siddiqui, Benjamin John Miller, Yakubu Karagama & Nicholas Gibbins. (2021) Non-aesthetic uses of botulinum toxin in the head and neck. European Archives of Oto-Rhino-Laryngology 278:11, pages 4147-4154.
Crossref
Mahmoud Sakr. 2021. Diagnostic Techniques and Therapeutic Strategies for Parotid Gland Disorders. Diagnostic Techniques and Therapeutic Strategies for Parotid Gland Disorders
296
323
.
E. Candau Pérez, M.J. Antón Andrés, A. Andrés Toribio & D. Pinilla García. (2018) Tratamiento de la hiperhidrosis secundaria a síndrome de Frey con toxina botulínica. A propósito de un caso. Rehabilitación 52:3, pages 195-197.
Crossref
Naomi Prado, Louisa Rose & Peter Korczak. (2018) Botox: It's Not Just About The Wrinkles. Dental Update 45:1, pages 32-37.
Crossref
Cyrus Kerawala, Kate Newbold, Francesco M.G. Riva, Derfel ap Dafydd & David Tighe. 2018. Oral, Head and Neck Oncology and Reconstructive Surgery. Oral, Head and Neck Oncology and Reconstructive Surgery
850
875
.
Lyndsay L. Madden & Clark A. Rosen. 2018. Neurolaryngology. Neurolaryngology
109
123
.
Benjamin C. Tweel & Ricardo Carrau. 2018. Gland-Preserving Salivary Surgery. Gland-Preserving Salivary Surgery
193
201
.
R. Laskawi & A. Olthoff. (2017) Botulinumtoxin in der HNO‑Heilkunde – ein UpdateBotulinum toxin in otorhinolaryngology – an update. HNO 65:10, pages 859-870.
Crossref
Dee Anna Glaser & Adam R. Mattox. 2017. Botulinum Toxins. Botulinum Toxins
299
315
.
S. Jansen, M. Jerowski, L. Ludwig, E. Fischer-Krall, D. Beutner & M. Grosheva. (2017) Botulinum toxin therapy in Frey's syndrome: a retrospective study of 440 treatments in 100 patients. Clinical Otolaryngology 42:2, pages 295-300.
Crossref
Ravleen Nagi, Deepa Jatti Patil, Shashikant Sahu, Supreet Jain & Giridhar S. Naidu. (2017) Botulinum toxin in the management of head and neck disorders. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 123:4, pages 419-428.
Crossref
Kamran Habib Awan. (2017) The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions – An evidence based review. Saudi Pharmaceutical Journal 25:1, pages 18-24.
Crossref
Michael D. Chambers & William Chung. 2017. Complications of Temporomandibular Joint Surgery. Complications of Temporomandibular Joint Surgery
75
80
.
Kyung-Soo ParkChi-Heun LeeJung-Woo Lee. (2016) Use of a botulinum toxin A in dentistry and oral and maxillofacial surgery. Journal of Dental Anesthesia and Pain Medicine 16:3, pages 151.
Crossref
Shang Xie, Kan Wang, Tao Xu, Xue‐Sheng Guo, Xiao‐Feng Shan & Zhi‐Gang Cai. (2015) Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles. Cancer Medicine 4:11, pages 1639-1650.
Crossref
Niv Mor, Christropher Tang & Andrew Blitzer. (2015) Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection. Toxins 7:8, pages 2791-2800.
Crossref
Chunjie Li, Fanglong Wu, Qi Zhang, Qinghong Gao, Zongdao Shi & Longjiang Li. (2015) Interventions for the treatment of Frey's syndrome. Cochrane Database of Systematic Reviews.
Crossref
Ahmad Alshadwi, Mohammed Nadershah & Timothy Osborn. (2015) Therapeutic applications of botulinum neurotoxins in head and neck disorders. The Saudi Dental Journal 27:1, pages 3-11.
Crossref
Ugur Demirci, Oguz Basut, Behzat Noyan, Uygar Levent Demir, O. Afsin Ozmen, Fikret Kasapoglu, H. Hakan Coskun & Selcuk Onart. (2012) The Efficiacy of Sternocleidomastoid Muscle Flap on Frey’s Syndrome via a Novel Test: Galvanic Skin Response. Indian Journal of Otolaryngology and Head & Neck Surgery 66:S1, pages 291-298.
Crossref
Osman Durgut, Oguz Basut, Uygar Levent Demir, Ömer A. Özmen, Fikret Kasapoglu & Hakan Coskun. (2013) Association between skin flap thickness and Frey's syndrome in parotid surgery. Head & Neck 35:12, pages 1781-1786.
Crossref
T. Lopes, L. Barroso, M. Mesquita, S. Bitoque, D. Lopez & A. Ferreira. (2013) Síndrome de Frey – Uma visão global do tema. Revista Portuguesa de Estomatologia, Medicina Dentária e Cirurgia Maxilofacial 54:2, pages 103-114.
Crossref
Ricardo Persaud, George Garas, Sanjeev Silva, Constantine Stamatoglou, Paul Chatrath & Kalpesh Patel. (2013) An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Reports 4:2, pages 1-9.
Crossref
F. Ihler, R. Laskawi, C. Matthias, H.H. Rustenbeck & M. Canis. (2012) Botulinumtoxin A gegen HypersalivationBotulinum toxin A for drooling. HNO 60:6, pages 524-527.
Crossref
A Steffen, N Rotter, I R König & B Wollenberg. (2011) Botulinum toxin for Frey's syndrome: a closer look at different treatment responses. The Journal of Laryngology & Otology 126:2, pages 185-189.
Crossref
Y. Z. Chiang, F. Al-Niaimi & J. Yell. (2012) Transient erythematous rash on the cheek mimicking food allergy. Clinical and Experimental Dermatology 37:1, pages 89-90.
Crossref
Dee Anna Glaser. 2011. Botulinum Toxins in Clinical Aesthetic Practice. Botulinum Toxins in Clinical Aesthetic Practice
248
262
.
Dee Anna Glaser. 2011. Cosmetic Bootcamp Primer. Cosmetic Bootcamp Primer
115
129
.
Y A Yutskovskaya & M S Tarasenkova. (2010) Practical aspects of correction of local hyperhidrosis with the application of abotulinum toxin type A (Dysport®). Vestnik dermatologii i venerologii 86:5, pages 161-167.
Crossref
Giovanna Cantarella, Alessandra Berlusconi, Vincenzo Mele, Filippo Cogiamanian & Sergio Barbieri. (2010) Treatment of Frey's syndrome with botulinum toxin type B. Otolaryngology–Head and Neck Surgery 143:2, pages 214-218.
Crossref
Vincent L. M. Vander Poorten, Francis Marchal, Sandra Nuyts & Paul M. J. Clement. (2010) Parotid carcinoma: Current diagnostic workup and treatment. Indian Journal of Surgical Oncology 1:2, pages 96-111.
Crossref
O.W. Majid. (2010) Clinical use of botulinum toxins in oral and maxillofacial surgery. International Journal of Oral and Maxillofacial Surgery 39:3, pages 197-207.
Crossref
Luis Javier López del Val, Alfonso Castro García, Laura Martínez Martínez & Elena López García. 2010. Toxina Botulínica. Toxina Botulínica
415
436
.
Isabel Aldanondo Fernández de la Mora & Pedro Jaén Olasolo. 2010. Toxina Botulínica. Toxina Botulínica
383
411
.
Dee Anna Glaser & Markus Naumann. 2009. Botulinum Toxin. Botulinum Toxin
308
323
.
D M Hartl, M Julieron, A-M LeRidant, F Janot, P Marandas & J-P Travagli. (2008) Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome). The Journal of Laryngology & Otology 122:10, pages 1100-1104.
Crossref
Pasquale Capaccio, Sara Torretta, Maurizio Osio, Davide Minorati, Francesco Ottaviani, Giuseppe Sambataro, Cristina Nascimbene & Lorenzo Pignataro. (2008) Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders. American Journal of Otolaryngology 29:5, pages 333-338.
Crossref
Victor Helmstaedter, Claus Wittekindt, Karl‐Bernd Huttenbrink & Orlando Guntinas‐Lichius. (2009) Safety and Efficacy of Botulinum Toxin Therapy in Otorhinolaryngology: Experience From 1,000 Treatments. The Laryngoscope 118:5, pages 790-796.
Crossref
Laurent Laccourreye, Alfred Werner & Ollivier Laccourreye. (2008) Comment diagnostiquer et traiter les syndromes de Frey ?. Annales d'Otolaryngologie et de Chirurgie Cervico-faciale 125:1, pages 58-62.
Crossref
Jan Rustemeyer, Harald Eufinger & Andreas Bremerich. (2008) The incidence of Frey's syndrome. Journal of Cranio-Maxillofacial Surgery 36:1, pages 34-37.
Crossref
John C. Sok & Clark A. Rosen. 2008. Operative Otolaryngology: Head and Neck Surgery. Operative Otolaryngology: Head and Neck Surgery
495
498
.
Berna Uslu Coskun, Hayati Savk, Esin Derin Cicek, Tulay Basak, Muzaffer Basak & Burhan Dadas. (2007) Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat. European Archives of Oto-Rhino-Laryngology 264:7, pages 783-787.
Crossref
Imran Rahman & S. Ahmed Sadiq. (2007) Ophthalmic Management of Facial Nerve Palsy: A Review. Survey of Ophthalmology 52:2, pages 121-144.
Crossref
Pavel Dulguerov. 2007. Salivary Gland Disorders. Salivary Gland Disorders
111
125
.
Phillip Song, Jerome S. Schwartz & Andrew Blitzer. 2007. Therapeutic Uses of Botulinum Toxin. Therapeutic Uses of Botulinum Toxin
123
135
.
Mark A. Clayman, Scott M. Clayman & M Brent Seagle. (2006) A Review of the Surgical and Medical Treatment of Frey Syndrome. Annals of Plastic Surgery 57:5, pages 581-584.
Crossref
Daniel D. Truong & Wolfgang H. Jost. (2006) Botulinum toxin: Clinical use. Parkinsonism & Related Disorders 12:6, pages 331-355.
Crossref
W. H. Jost. (2006) Other indications of botulinum toxin therapy. European Journal of Neurology 13, pages 65-69.
Crossref
D. Dressler & M. Hallett. (2006)
Immunological aspects of Botox
®
, Dysport
®
and Myobloc
TM
/NeuroBloc
®
. European Journal of Neurology 13, pages 11-15.
Crossref
Wolfgang H. Jost. (2006) Botulinum toxin in multiple sclerosis. Journal of Neurology 253:S1, pages i16-i20.
Crossref
Boris Petelle, Elisabeth Sauvaget & Patrice Tran Ba Huy. (2006) Parotidectomies. EMC - Techniques chirurgicales - Tête et cou 1:1, pages 1-11.
Crossref
Eric A. Johnson, Gary E. Borodic & Martin A. Acquadro. 2006. The Comprehensive Sourcebook of Bacterial Protein Toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins
959
975
.
Chen-Chi Wang & Ching-Ping Wang. (2005) Preliminary Experience with Botulinum Toxin Type A Intracutaneous Injection for Frey's Syndrome. Journal of the Chinese Medical Association 68:10, pages 463-467.
Crossref
A. Acher-Chenebaux, H. Maillard, A. Potier, P. Lejoyeux & P. Célérier. (2005) Traitement d’un syndrome de Frey par des injections de toxine botulique A. Annales de Dermatologie et de Vénéréologie 132:8-9, pages 703-705.
Crossref
James Keir. (2005) Botulinum toxin—physiology and applications in head and neck disorders. Head & Neck 27:6, pages 525-535.
Crossref
Korhan AsalAhmet KöybaşioğluErdoğan InalAhmet UralS. Sabri UsluAlper CeylanFikret Ileri. (2005) Sternocleidomastoid Muscle Flap Reconstruction during Parotidectomy to Prevent Frey's Syndrome and Facial Contour Deformity. Ear, Nose & Throat Journal 84:3, pages 173-176.
Crossref
S. Santa Cruz Ruiz, A. Muñoz Herrera, P. Santa Cruz Ruiz, M. Gil Melcon & A. Batuecas Caletrio. (2005) Síndrome de Frey idiopático bajo la apariciencia de una otitis externa recidivante. Tratamiento con neuro-toxina botulínica tipo A. Acta Otorrinolaringológica Española 56:2, pages 83-85.
Crossref
S. Rohrbach & R. Laskawi. 2005. Funktionsstörungen und funktionelle Störungen. Funktionsstörungen und funktionelle Störungen
53
76
.
Marc Heckmann. 2005. Dermatologie und Venerologie. Dermatologie und Venerologie
910
922
.
D. Nolte, I. Gollmitzer, D. J. Loeffelbein, F. H�lzle & K.-D. Wolff. (2004) Botulinumtoxin zur Behandlung des gustatorischen SchwitzensBotulinum toxin for treatment of gustatory sweating. Mund-, Kiefer- und Gesichtschirurgie 8:6, pages 369-375.
Crossref
Dionysios E Kyrmizakis, Aris Pangalos, Chariton E Papadakis, John Logothetis, Nicolas J Maroudias & Emmanuel S Helidonis. (2004) The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. Journal of Oral and Maxillofacial Surgery 62:7, pages 840-844.
Crossref
Abigail Arad & Andrew Blitzer. (2004) Botulinum toxin in the treatment of autonomic nervous system disorders. Operative Techniques in Otolaryngology-Head and Neck Surgery 15:2, pages 118-121.
Crossref
Kuauhyama Luna-Ortiz, Jesús Alberto Sansón-Rı́oFrı́o & Adalberto Mosqueda-Taylor. (2004) Frey syndrome. A proposal for evaluating severity. Oral Oncology 40:5, pages 501-505.
Crossref
Markus Naumann & Wolfgang Jost. (2004) Botulinum toxin treatment of secretory disorders. Movement Disorders 19:S8, pages S137-S141.
Crossref
M. Zouhair Atassi. (2004) Basic immunological aspects of botulinum toxin therapy. Movement Disorders 19:S8, pages S68-S84.
Crossref
Boris Petelle, Elisabeth Sauvaget & Patrice Tran Ba Huy. (2004) Parotidectomías. EMC - Cirugía Otorrinolaringológica y Cervicofacial 5:1, pages 1-12.
Crossref
Boris Petelle, Elisabeth Sauvaget & Patrice Tran Ba Huy. (2004) Parotidectomías. EMC - Cirugía General 4:1, pages 1-12.
Crossref
. 2004. Botulinum Toxin in Facial Rejuvenation. Botulinum Toxin in Facial Rejuvenation
143
146
.
Reinhard K. AchenbachReinhard K. Achenbach. 2004. Hyperhidrosis. Hyperhidrosis
121
160
.
Reinhard K. AchenbachReinhard K. Achenbach. 2004. Hyperhidrosis. Hyperhidrosis
57
88
.
Ib R Odderson. (2003) Treatment of hyperhidrosis and drooling with botulinum exotoxin. Physical Medicine and Rehabilitation Clinics of North America 14:4, pages 837-854.
Crossref
André Eckardt & Christian Kuettner. (2003) Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A. Head & Neck 25:8, pages 624-628.
Crossref
S Périé & J Lacau St Guily. (2003) Indications de la neurotoxine botulique A en neuro-ORL. Annales de Réadaptation et de Médecine Physique 46:6, pages 375-379.
Crossref
Hélio A.G. Teive, André R. Troiano, Fábio Robert, Fábio M. Iwamoto, João J. Maniglia, Marcos Mocellin & Lineu César Werneck. (2003) Botulinum toxin for treatment of Frey's syndrome: report of two cases. Arquivos de Neuro-Psiquiatria 61:2A, pages 256-258.
Crossref
Richard G. Glogau. (2002) Review of the Use of Botulinum Toxin for Hyperhidrosis and Cosmetic Purposes. The Clinical Journal of Pain 18:Supplement, pages S191-S197.
Crossref
F J Montoya, C E Riddell, R Caesar & S Hague. (2002) Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye 16:6, pages 705-709.
Crossref
Jennifer Clay Cather, J.Christian Cather & Alan Menter. (2002) Update on botulinum toxin for facial aesthetics. Dermatologic Clinics 20:4, pages 749-761.
Crossref
Rafael Reisfeld, Raymond Nguyen & Alon Pnini. (2002) Endoscopic Thoracic Sympathectomy for Hyperhidrosis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 12:4, pages 255-267.
Crossref
Frank Birklein, Dirk Walther, Hans Bigalke, Martin Winterholler & Frank Erbguth. (2002) Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies. Annals of Neurology 52:1, pages 68-73.
Crossref
Vincent L. M. Vander Poorten, Alfonsus J. M. Balm & Frans J. M. Hilgers. (2002) Management of cancer of the parotid gland. Current Opinion in Otolaryngology & Head and Neck Surgery 10:2, pages 134-144.
Crossref
Joyce R. Grissom. 2002. Elextrodiagnostic Medicine. Elextrodiagnostic Medicine
479
512
.
Otto Braun-FalcoM. Heckmann. 2002. Fortschritte der Dermatologie. Fortschritte der Dermatologie
61
74
.
Constantin E. Orfanos & Claus GarbeConstantin E. Orfanos & Claus Garbe. 2002. Therapie der Hautkrankheiten. Therapie der Hautkrankheiten
773
791
.
S. Glickman & C. N. Deaney. (2001) Treatment of relative sialorrhoea with botulinum toxin type A: description and rationale for an injection procedure with case report. European Journal of Neurology 8:6, pages 567-571.
Crossref
Carl Swartling, Catarina Färnstrand, Gregor Abt, Erik Stålberg & Hans Naver. (2001) Side‐effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. European Journal of Neurology 8:5, pages 451-456.
Crossref
P. Schnider, E. Moraru, H. Kittler, M. Binder, G. Kranz, B. Voller & E. Auff. (2001) Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. British Journal of Dermatology 145:2, pages 289-293.
Crossref
Richard G. Glogau. (2001) Treatment of palmar hyperhidrosis with botulinum toxin. Seminars in Cutaneous Medicine and Surgery 20:2, pages 101-108.
Crossref
C. Swartling, H. Naver & M. Lindberg. (2001) Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. European Journal of Neurology 8:3, pages 247-252.
Crossref
Marc Heckmann, Andrés O. Ceballos-Baumann & Gerd Plewig. (2001) Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating). New England Journal of Medicine 344:7, pages 488-493.
Crossref
P. Schnider, D. Földy & E. Auff. 2001. Infektiologie Aktuelle Aspekte. Infektiologie Aktuelle Aspekte
91
102
.
Jens-Jörg von Lindern, Bernd Niederhagen, Stefaan Bergé & Rudolf H. Reich. (2000) Treatment of Frey's syndrome with type a botulinum toxin: Case report. Journal of Oral and Maxillofacial Surgery 58:12, pages 1411-1414.
Crossref
Maik Ellies, Rainer Laskawi, Gesine Tormählen ‡Werner Götz. (2000) The effect of local injection of botulinum toxin A on the parotid gland of the rat: An immunohistochemical and morphometric study. Journal of Oral and Maxillofacial Surgery 58:11, pages 1251-1256.
Crossref
Jens J. von Lindern, Bernd Niederhagen, Stefan Berg�, Georg H�gler & Rudolf H. Reich. (2000) Frey syndrome. Cancer 89:8, pages 1659-1663.
Crossref
M. Rodriguez‐Serna, J. I. Marí & A. Aliaga. (2001) Auriculotemporal Nerve (Frey) Syndrome. Pediatric Dermatology 17:5, pages 415-416.
Crossref
Holger G. Gassner & David A. Sherris. (2000) Addition of an Anesthetic Agent to Enhance the Predictability of the Effects of Botulinum Toxin Type A Injections: A Randomized Controlled Study. Mayo Clinic Proceedings 75:7, pages 701-704.
Crossref
HOLGER G. GASSNER & DAVID A. SHERRIS. (2000) Addition of an Anesthetic Agent to Enhance the Predictability of the Effects of Botulinum Toxin Type A Injections: A Randomized Controlled Study. Mayo Clinic Proceedings 75:7, pages 701-704.
Crossref
Pavel Dulguerov, Didier Quinodoz, Grégoire Cosendai, Pierre Piletta & Willy Lehmann. (2016) Frey Syndrome Treatment with Botulinum Toxin. Otolaryngology–Head and Neck Surgery 122:6, pages 821-827.
Crossref
Andrew C. Markey. (2000) Botulinum A exotoxin in cosmetic dermatology. Clinical and Experimental Dermatology 25:3, pages 173-175.
Crossref
Steven Kaddu, Josef Smolle, Peter Komericki & Helmut Kerl. (2001) Auriculotemporal (Frey) Syndrome in Late Childhood: An Unusual Variant Presenting as Gustatory Flushing Mimicking Food Allergy. Pediatric Dermatology 17:2, pages 126-128.
Crossref
Rafael Reisfeld, Raymond Nguyen & Alon Pnini. (2000) Endoscopic Thoracic Sympathectomy for Treatment of Essential Hyperhidrosis Syndrome: Experience With 650 Patients. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 10:1, pages 5-10.
Crossref
Rafael Reisfeld, Raymond Nguyen & Alon Pnini. (2000) Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 10:1, pages 5-10.
Crossref
Abigail Arad‐Cohen & Andrew Blitzer. (2016) Botulinum toxin treatment for symptomatic Frey's syndrome. Otolaryngology–Head and Neck Surgery 122:2, pages 237-240.
Crossref
H. Naver, C. Swartling & S.‐M. Aquilonius. (2001) Palmar and axillary hyperhidrosis treated with botulinum toxin: one‐year clinical follow‐up. European Journal of Neurology 7:1, pages 55-62.
Crossref
Otto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. BurgdorfOtto Braun-Falco, Gerd Plewig, Helmut H. Wolff & Walter H. C. Burgdorf. 2000. Dermatology. Dermatology
1087
1097
.
Frank Birklein & Frank Erbguth. (2000) Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A?A preliminary observation. Movement Disorders 15:1, pages 146-149.
Crossref
Marc Heckmann, Susanne Breit, Andres Ceballos-Baumann, Martin Schaller & Gerd Plewig. (1999) Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. Journal of the American Academy of Dermatology 41:6, pages 987-990.
Crossref
Gary Borodic. (1999) Botulinum toxin: issues and applications. Current Opinion in Otolaryngology & Head and Neck Surgery 7:4, pages 219.
Crossref
Anna Rita Bentivoglio & Alberto Albanese. (1999) Botulinum toxin in motor disorders. Current Opinion in Neurology 12:4, pages 447-456.
Crossref
S. Sood, M. S. Quraishi, C. R. Jennings & P. J. Bradley. (1999) Frey's syndrome following parotidectomy: prevention using a rotation sternocleidomastoid muscle flap. Clinical Otolaryngology and Allied Sciences 24:4, pages 365-368.
Crossref
A.B. Moody, C.M.E. Avery, J. Taylor & J.D. Langdon. (1999) A comparison of one hundred and fifty consecutive parotidectomies for tumours and inflammatory disease. International Journal of Oral and Maxillofacial Surgery 28:3, pages 211-215.
Crossref
SCHNIDER, BINDER, KITTLER, BIRNER, STARKEL, WOLFF & AUFF. (1999) A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. British Journal of Dermatology 140:4, pages 677-680.
Crossref
Timothy A. Miller. (1999) DYNAMIC TECHNIQUE: THREE-FLAP SMAS. Plastic and Reconstructive Surgery 103:2, pages 745.
Crossref
Marc Heckmann. 1999. Vorträge und Dia-Klinik der 16. Fortbildungswoche 1998 Fortbildungswoche für Praktische Dermatologie und Venerologie e.V. c/o Klinik und Poliklinik für Dermatologie und Allergologie Ludwig-Maximilians-Universität München in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V.. Vorträge und Dia-Klinik der 16. Fortbildungswoche 1998 Fortbildungswoche für Praktische Dermatologie und Venerologie e.V. c/o Klinik und Poliklinik für Dermatologie und Allergologie Ludwig-Maximilians-Universität München in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V.
387
392
.
Dr Susan Holmes & Dr Cameron Mann. (1998) Botulinum toxin in the treatment of palmar hyperhidrosis. Journal of the American Academy of Dermatology 39:6, pages 1040-1041.
Crossref
IB R. ODDERSON. (1998) Hyperhidrosis Treated by Botulinum A Exotoxin. Dermatologic Surgery 24:11, pages 1237-1241.
Crossref
RICHARD G. GLOGAU. (1998) Botulinum A Neurotoxin for Axillary Hyperhidrosis No Sweat Botox. Dermatologic Surgery 24:8, pages 817-819.
Crossref
S. Sood, M. S. Quraishi & P. J. Bradley. (1998) Frey's syndrome and parotid surgery. Clinical Otolaryngology and Allied Sciences 23:4, pages 291-301.
Crossref
Rainer Laskawi, Christian Drobik & Claudia Schönebeck. (1998) Up-to-date Report of Botulinum Toxin Type A Treatment in Patients With Gustatory Sweating (Frey's Syndrome). The Laryngoscope 108:3, pages 381-384.
Crossref
Ib R. Odderson. (1998) Axillary hyperhidrosis: Treatment with botulinum toxin A. Archives of Physical Medicine and Rehabilitation 79:3, pages 350-352.
Crossref
Ollivier Laccourreye, Luca Muscatelo, Carole Naude, Brigitte Bonan & Daniel Brasnu. (2016) Botulinum Toxin Type a for Frey's Syndrome: A Preliminary Prospective Study. Annals of Otology, Rhinology & Laryngology 107:1, pages 52-55.
Crossref
M. HECKMANN, M. SCHALLER, A. CEBALLOS-BAUMANN & G PLEWIG. (1997) Botulinum beyond Wrinkles. Dermatologic Surgery 23:12, pages 1221-1222.
Crossref
A. Bjerkhoel & O. Trobbe. (2007) Frey's syndrome: treatment with botulinum toxin. The Journal of Laryngology & Otology 111:9, pages 839-844.
Crossref
P. SCHNIDER, M. BINDER, E. AUFF, H. KITTLER, T. BERGER & K. WOLFF. (1997) Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. British Journal of Dermatology 136:4, pages 548-552.
Crossref
P. SCHNIDER, M. BINDER, E. AUFF, H. KITTLER, T. BERGER & K. WOLFF. (1997) Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. British Journal of Dermatology 136:4, pages 548-552.
Crossref
Peter Schnider, Michael Binder, Harald Kittler, Nikolaus Steinhoff & Eduard Auff. (1997) Uses of botulinum toxin. The Lancet 349:9056, pages 953.
Crossref
Markus Naumann, Peter Flachenecker, Eva-B Bröcker, Klaus V Toyka & Karlheinz Reiners. (1997) Botulinum toxin for palmar hyperhidrosis. The Lancet 349:9047, pages 252.
Crossref
A. Schulze-Bonhage, M. Schröder & A. Ferbert. (1996) Botulinum toxin in the therapy of gustatory sweating. Journal of Neurology 243:2, pages 143-146.
Crossref